PlainPill

Melanotan-2 vs Testosterone for libido

Short answer: For libido, more users report improvement with Melanotan-2 — 100% of 7 reports, versus 93% of 70 for Testosterone.

Melanotan-2 has 0 meta-analyses and 0 randomized trials on PubMed; Testosterone has 75 and 125.

Based on 13 reports about Melanotan-2 and 822 about Testosterone. Not medical advice.

Melanotan-2
Peptide
Testosterone
Medication
User score3554
Verdict
Mostly positive
Mostly positive
Positive
of reports that state an outcome
87%77%
Reports13822
ResearchDResearch: NoneAResearch: Strong
Meta-analyses / RCTs0 / 075 / 125
Mainly used for
Weight loss
% reporting improvement
—93% (45)
Focus
% reporting improvement
—82% (28)
Energy
% reporting improvement
—92% (76)
Sleep
% reporting improvement
—79% (19)
Anxiety
% reporting improvement
—80% (25)
Mood
% reporting improvement
—88% (104)
Memory
% reporting improvement
—100% (2)
Performance
% reporting improvement
—97% (149)
Recovery
% reporting improvement
—91% (23)
Pain & inflammation
% reporting improvement
—67% (6)
Libido
% reporting improvement
100% (7)93% (70)
Hormones
% reporting improvement
—90% (91)
Heart & lipids
% reporting improvement
—62% (8)
Skin & hair
% reporting improvement
100% (5)40% (5)
Longevity
% reporting improvement
—50% (2)
Common side effectsnausea, flushing, darkening, enlarged molessuppression, hair loss, acne, water retention
Typical dose reportedNot listed200 mg / weekly
Melanotan-2
What a user said
“MT2 has noticeably increased my libido, and honestly the biggest benefit for me has been the tan.”
Full Melanotan-2 profile →
Testosterone
Latest review conclusion

The guidelines also provide recommendations regarding identification of patients, dosing, monitoring, and follow-up. This Practice Pearl will discuss evidence-based testosterone therapy for management of HSDD in postmenopausal women.

Menopause, 2023 ↗
What a user said
“Feel the best I've ever felt in my life. TRT and peptides have been game changers for me!”
Full Testosterone profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate